https://www.seattlechildrens.org/research/research-studies-clinical-trials/current-studies/all/acns1833-a-phase-3-randomized-non-inferiority-study-of-carboplatin-and-vincristine-versus-selumetinibnsc-748727-ind-77782-in-newly-diagnosed-or-previously-untreated-low-grade-glioma-lggnot-associated-with-brafv600e-mutations-or-s-study00002369/
ACNS1833, A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus...
To demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior compared to treatment with...
non inferiority study